132 related articles for article (PubMed ID: 31085038)
1. Anaphylaxis preceded by erythema multiforme with sorafenib: First case report.
Mantovani A; Álvares-Da-Silva MR
Ann Hepatol; 2019; 18(5):777-779. PubMed ID: 31085038
[TBL] [Abstract][Full Text] [Related]
2. [Two cases of successful sorafenib retreatment with the addition of steroid therapy following sorafenib-induced erythema multiforme in two patients with hepatocellular carcinoma].
Shioya M; Nishimura T; Nishida A; Inatomi O; Bamba S; Sasaki M; Andoh A; Fujiyama Y
Nihon Shokakibyo Gakkai Zasshi; 2014 Jul; 111(7):1424-32. PubMed ID: 24998734
[TBL] [Abstract][Full Text] [Related]
3. Sorafenib-induced erythema multiforme in metastatic renal cell carcinoma.
Bilaç C; Müezzinoğlu T; Ermertcan AT; Kayhan TC; Temeltaş G; Oztürkcan S; Temiz P
Cutan Ocul Toxicol; 2009; 28(2):90-2. PubMed ID: 19514932
[TBL] [Abstract][Full Text] [Related]
4. Erythema multiforme induced by sorafenib for metastatic renal cell carcinoma.
Ikeda M; Fujita T; Mii S; Tanabe K; Tabata K; Matsumoto K; Satoh T; Iwamura M
Jpn J Clin Oncol; 2012 Sep; 42(9):820-4. PubMed ID: 22782962
[TBL] [Abstract][Full Text] [Related]
5. Successful Treatment of Hepatocellular Carcinoma with Regorafenib after Sorafenib-induced Hypersensitivity.
Yoshioka N; Kuzuya T; Ito T; Ishizu Y; Honda T; Ishikawa T; Ishigami M; Fujishiro M
Intern Med; 2019 Oct; 58(19):2803-2808. PubMed ID: 31243207
[TBL] [Abstract][Full Text] [Related]
6. Severe hand-foot skin reaction and erythema multiforme-like lesions due to sorafenib.
Guliani A; Daroach M; Aggarwal D; Radotra BD; Kumaran MS
Postgrad Med J; 2018 Sep; 94(1115):535-536. PubMed ID: 30224351
[No Abstract] [Full Text] [Related]
7. Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis.
Pinter M; Sieghart W; Graziadei I; Vogel W; Maieron A; Königsberg R; Weissmann A; Kornek G; Plank C; Peck-Radosavljevic M
Oncologist; 2009 Jan; 14(1):70-6. PubMed ID: 19144684
[TBL] [Abstract][Full Text] [Related]
8. Sorafenib induced hepatic encephalopathy.
Sidhu SS; Agarwal S; Goyal O; Kishore H; Sidhu S
Acta Gastroenterol Belg; 2017; 80(4):537-538. PubMed ID: 29560652
[TBL] [Abstract][Full Text] [Related]
9. A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver transplantation.
Eilard MS; Andersson M; Naredi P; Geronymakis C; Lindnér P; Cahlin C; Bennet W; Rizell M
BMC Cancer; 2019 Jun; 19(1):568. PubMed ID: 31185950
[TBL] [Abstract][Full Text] [Related]
10. Leukocytoclastic vasculitis associated with sorafenib treatment for hepatocellular carcinoma.
Prejac J; Kekez D; Belev B; Kocić L; Bulimbašić S; Pleština S
Anticancer Drugs; 2020 Jan; 31(1):76-79. PubMed ID: 31567309
[TBL] [Abstract][Full Text] [Related]
11. Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study.
Reiss KA; Yu S; Mamtani R; Mehta R; D'Addeo K; Wileyto EP; Taddei TH; Kaplan DE
J Clin Oncol; 2017 Nov; 35(31):3575-3581. PubMed ID: 28872925
[TBL] [Abstract][Full Text] [Related]
12. Psoriasiform drug eruption secondary to sorafenib: case series and review of the literature.
Ensslin CJ; Kao PH; Wu MY; Chang YY; Kuo TT; Hsieh CH; Hsieh SY; Yang CH; Miller LS
Cutis; 2019 Sep; 104(3):E11-E15. PubMed ID: 31675404
[TBL] [Abstract][Full Text] [Related]
13. Combined hepatocellular-cholangiocarcinoma successfully treated with sorafenib: case report and review of the literature.
Futsukaichi Y; Tajiri K; Kobayashi S; Nagata K; Yasumura S; Takahara T; Minemura M; Yasuda I
Clin J Gastroenterol; 2019 Apr; 12(2):128-134. PubMed ID: 30374884
[TBL] [Abstract][Full Text] [Related]
14. Sorafenib-induced erythema multiforme for metastatic renal cell carcinoma.
Kodaira M; Takahashi S; Takeuchi K; Yuasa T; Saotome T; Yonese J; Fukui I; Hatake K
Ann Oncol; 2010 Jul; 21(7):1563-1565. PubMed ID: 20573851
[No Abstract] [Full Text] [Related]
15. Rowell Syndrome in Nigeria: Systemic Lupus Erythematosus Presenting as Recurrent Erythema Multiforme in a Young Woman.
Akintayo RO; Olarinoye GM; Akintayo FC; Ilesanmi ON
Acta Dermatovenerol Croat; 2019 Sep; 27(3):200-201. PubMed ID: 31542069
[TBL] [Abstract][Full Text] [Related]
16. Management of cirrhotic patients with hepatocellular carcinoma treated with sorafenib.
Cabibbo G; Rolle E; De Giorgio M; Genco C; Pressiani T; Spada F; Sacco R;
Expert Rev Anticancer Ther; 2011 Dec; 11(12):1807-16. PubMed ID: 22049974
[TBL] [Abstract][Full Text] [Related]
17. Sorafenib-induced erythema annulare centrifugum with spontaneous resolution after skin biopsy.
Yao CA
Australas J Dermatol; 2018 May; 59(2):e150-e151. PubMed ID: 28726329
[No Abstract] [Full Text] [Related]
18. Acute hepatitis in a patient with cirrhosis and hepatocellular carcinoma treated with sorafenib.
Llanos L; Bellot P; Zapater P; Pérez-Mateo M; Such J
Am J Gastroenterol; 2009 Jan; 104(1):257-8. PubMed ID: 19098892
[No Abstract] [Full Text] [Related]
19. [Nodulocystic eruption induced by sorafenib].
Chambelland A; Koeppel MC; Desmedt E; Fongue J; Buono JP; Berbis P; Delaporte E
Ann Dermatol Venereol; 2019 Oct; 146(10):646-654. PubMed ID: 31362839
[TBL] [Abstract][Full Text] [Related]
20. Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib.
Brunetti O; Gnoni A; Licchetta A; Longo V; Calabrese A; Argentiero A; Delcuratolo S; Solimando AG; Casadei-Gardini A; Silvestris N
Medicina (Kaunas); 2019 Oct; 55(10):. PubMed ID: 31640191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
